Clinical Trials Browser

INDUSTRY × Astrocytoma × Semustine × Clear all

NCT00335075 2017-05-15

Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)

Phase 3 Completed

Astrocytoma, Glioblastoma